Cannabis Stocks on the Rise: A Path to Recovery

By
Sandy Caputo

Recent discussions among analysts reveal a growing optimism about the future of cannabis stocks, predicting a rebound as the industry moves toward rescheduling. This potential regulatory change is expected to provide much-needed stability and boost investor confidence.

HQ Magazine’s Perspective

The cannabis market has faced significant volatility, but the path to rescheduling offers hope for recovery. The anticipation of federal policy changes is driving positive sentiment in the market. Analysts at Cantor Fitzgerald, including Pablo Zuanic, predict a favorable outcome if the U.S. Drug Enforcement Administration (DEA) reclassifies marijuana from a Schedule I to a Schedule III drug. This move would not only alleviate some of the financial burdens on cannabis companies but also open doors for increased institutional investment.

Data Highlights

  • AdvisorShares Pure US Cannabis ETF: Rose by 26% in less than an hour, reflecting growing investor optimism.
  • Rescheduling Impact: A shift from Schedule I to Schedule III could reduce federal tax obligations under Section 280E of the Internal Revenue Code, which currently prevents cannabis businesses from deducting standard business expenses.
  • Market Reaction: The potential for rescheduling is already attracting attention, with many anticipating that it will lead to a significant influx of capital into the market.

The Road Ahead

While the exact timeline for rescheduling remains uncertain, the positive sentiment among analysts highlights the importance of regulatory advancements for the cannabis industry. Stakeholders should remain vigilant and proactive in adapting to the evolving landscape. This includes bolstering operational efficiencies, securing strategic partnerships, and staying informed about policy developments to capitalize on future opportunities.

Strategic Moves for Companies

  1. Strengthen Operations: Cannabis companies should focus on streamlining their operations to ensure they are well-positioned to handle increased demand and competition.
  2. Policy Awareness: Keeping abreast of regulatory changes will be crucial. Companies should be prepared to adapt quickly to new regulations and leverage them to their advantage.
  3. Investor Relations: Building strong relationships with investors will be key. Transparent communication about the company’s strategic direction in light of potential rescheduling can help attract and retain investors.

The Bigger Picture

The cannabis industry is at a pivotal moment. The potential reclassification by the DEA could be a game-changer, offering the stability and clarity needed for long-term growth. As the industry matures, companies that are proactive and adaptive will be best positioned to thrive.

For more detailed analysis, visit MJBizDaily.

Recent Stories

Recent Articles

2026-08-05_10-11-53
By
Jimmy Wohl
Fragile Markets Need Sturdy Security
You’ve chosen to work in a gray area. You sell products that contain cannabis or cannabis-adjacent substances as well as accessories that can be used to consume it. And while that area has become less gray—you can see rays of sunlight peeking through—the skies are still cloudy. THC remains a Schedule 1 substance, even as medical marijuana has migrated to Schedule 3.
2026-07-30_23-43-05
By
Emily Long
What Retailers Wish They Knew When They Opened Their First Shop
Running a cannabis business is notoriously complicated. For dispensaries, complex compliance burdens permeate every facet of the business, from zoning and licensing to marketing and payments. Whether you’ve been in the cannabis space for mere months or multiple decades, you’ve likely run into drawn-out approval processes, supply chain headaches, or constantly changing regulation that makes compliance challenging, not to mention the other micro and macroeconomic factors that plague all small business owners.
3
By
Joe Reefer
Behind the Scenes: Not Ya Son’s Weed
Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
2026-07-30_20-13-55
By
Matt Weeks
Hawaiian Punch: One man’s fight to keep hemp legal
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
2026-07-30_8-12-05
By
Emily Long
Sula Benet and the Ancient History of Cannabis
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
2026-07-30_8-00-37
By
Matt Weeks
How North Carolina Could Save Us All
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
2026-07-30_7-49-06
By
Karen Maina
The Rise of Wellness Smoke Shops
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
CBD 3
By
Jimmy Wohl
Lung, Tongue, and Skin
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.